Cargando…
Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI
Functional MRI may identify critical windows of opportunity for drug delivery and distinguish between early treatment responders and non-responders. Using diffusion-weighted, dynamic contrast-enhanced, and dynamic susceptibility contrast MRI, as well as pro-angiogenic and pro-inflammatory blood mark...
Autores principales: | Ly, K. Ina, Vakulenko-Lagun, Bella, Emblem, Kyrre E., Ou, Yangming, Da, Xiao, Betensky, Rebecca A., Kalpathy-Cramer, Jayashree, Duda, Dan G., Jain, Rakesh K., Chi, Andrew S., Plotkin, Scott R., Batchelor, Tracy T., Sorensen, Gregory, Rosen, Bruce R., Gerstner, Elizabeth R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244161/ https://www.ncbi.nlm.nih.gov/pubmed/30459364 http://dx.doi.org/10.1038/s41598-018-34820-x |
Ejemplares similares
-
Publisher Correction: Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI
por: Ly, K. Ina, et al.
Publicado: (2019) -
Vascular dysfunction promotes regional hypoxia after bevacizumab therapy in recurrent glioblastoma patients
por: Gerstner, Elizabeth R, et al.
Publicado: (2020) -
Early changes in glioblastoma metabolism measured by MR spectroscopic imaging during combination of anti-angiogenic cediranib and chemoradiation therapy are associated with survival
por: Andronesi, Ovidiu C., et al.
Publicado: (2017) -
Repeatability of Cerebral Perfusion Using Dynamic Susceptibility Contrast MRI in Glioblastoma Patients()()
por: Jafari-Khouzani, Kourosh, et al.
Publicado: (2015) -
Vessel Architectural Imaging Identifies Cancer Patient Responders to Anti-angiogenic Therapy
por: Emblem, Kyrre E., et al.
Publicado: (2013)